CN109725141A - Sa-磁珠冻干工作液、sa-磁珠冻干品及冻干品的制备方法 - Google Patents
Sa-磁珠冻干工作液、sa-磁珠冻干品及冻干品的制备方法 Download PDFInfo
- Publication number
- CN109725141A CN109725141A CN201811571829.1A CN201811571829A CN109725141A CN 109725141 A CN109725141 A CN 109725141A CN 201811571829 A CN201811571829 A CN 201811571829A CN 109725141 A CN109725141 A CN 109725141A
- Authority
- CN
- China
- Prior art keywords
- freeze
- working solution
- aquatic products
- frozen aquatic
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011324 bead Substances 0.000 title claims abstract description 87
- 239000012224 working solution Substances 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000004108 freeze drying Methods 0.000 claims abstract description 72
- 239000000872 buffer Substances 0.000 claims abstract description 28
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims abstract description 18
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims abstract description 18
- 239000011734 sodium Substances 0.000 claims abstract description 17
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 17
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims abstract description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 239000003223 protective agent Substances 0.000 claims abstract description 7
- 238000004020 luminiscence type Methods 0.000 claims abstract description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 32
- 108010090804 Streptavidin Proteins 0.000 claims description 19
- 239000004471 Glycine Substances 0.000 claims description 16
- QYYMDNHUJFIDDQ-UHFFFAOYSA-N 5-chloro-2-methyl-1,2-thiazol-3-one;2-methyl-1,2-thiazol-3-one Chemical compound CN1SC=CC1=O.CN1SC(Cl)=CC1=O QYYMDNHUJFIDDQ-UHFFFAOYSA-N 0.000 claims description 12
- 230000005496 eutectics Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 238000003795 desorption Methods 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- -1 which is lyophilized Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims 4
- 239000011159 matrix material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 abstract description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract description 3
- 239000000427 antigen Substances 0.000 abstract description 3
- 102000036639 antigens Human genes 0.000 abstract description 3
- 108091007433 antigens Proteins 0.000 abstract description 3
- 229960002685 biotin Drugs 0.000 abstract description 3
- 235000020958 biotin Nutrition 0.000 abstract description 3
- 239000011616 biotin Substances 0.000 abstract description 3
- 239000000758 substrate Substances 0.000 abstract description 3
- 230000002255 enzymatic effect Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005092 sublimation method Methods 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IGLKELDWPZFFKF-UHFFFAOYSA-N OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.P.P Chemical compound OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.P.P IGLKELDWPZFFKF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Freezing, Cooling And Drying Of Foods (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811571829.1A CN109725141B (zh) | 2018-12-21 | 2018-12-21 | Sa-磁珠冻干工作液、sa-磁珠冻干品及冻干品的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811571829.1A CN109725141B (zh) | 2018-12-21 | 2018-12-21 | Sa-磁珠冻干工作液、sa-磁珠冻干品及冻干品的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109725141A true CN109725141A (zh) | 2019-05-07 |
CN109725141B CN109725141B (zh) | 2022-04-29 |
Family
ID=66296286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811571829.1A Active CN109725141B (zh) | 2018-12-21 | 2018-12-21 | Sa-磁珠冻干工作液、sa-磁珠冻干品及冻干品的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109725141B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110426513A (zh) * | 2019-05-23 | 2019-11-08 | 武汉三鹰生物技术有限公司 | 一种无外源蛋白干扰的elisa标准品的制备方法 |
CN110632322A (zh) * | 2019-08-27 | 2019-12-31 | 迪瑞医疗科技股份有限公司 | 载脂蛋白c2校准品的冻干制备工艺 |
CN111999509A (zh) * | 2020-08-10 | 2020-11-27 | 深圳市宇诺生物技术有限公司 | 抗缪勒氏管激素测定试剂盒、制备方法及检测方法 |
CN112748242A (zh) * | 2020-12-21 | 2021-05-04 | 珠海碳云智能科技有限公司 | 用于多肽芯片技术平台检测的二抗缓冲封闭液、包括其的试剂盒及其应用 |
CN113005117A (zh) * | 2021-02-26 | 2021-06-22 | 北京中科生仪科技有限公司 | 一种磁珠干化保护液、干化磁珠及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103472235A (zh) * | 2013-08-26 | 2013-12-25 | 河北省科学院生物研究所 | 一种长效蛋白质溶液稳定剂 |
CN104730253A (zh) * | 2015-03-20 | 2015-06-24 | 国家纳米科学中心 | 一种基于点击化学的检测试纸条、检测方法和应用 |
CN105445463A (zh) * | 2014-09-25 | 2016-03-30 | 苏州新波生物技术有限公司 | 一种戊肝IgG抗体检测试剂盒及其制备方法和应用 |
CN107656043A (zh) * | 2017-09-21 | 2018-02-02 | 苏州新波生物技术有限公司 | 一种c反应蛋白磁微粒检测试剂盒及其使用方法 |
CN108008125A (zh) * | 2017-12-18 | 2018-05-08 | 江苏浩欧博生物医药股份有限公司 | 一种适用于免疫磁珠的冻干工作液和免疫磁珠冻干品及其制备方法 |
CN108226481A (zh) * | 2018-01-08 | 2018-06-29 | 宁波紫园医疗器械有限公司 | 一种用于化学发光免疫检测试剂的磁珠试剂 |
CN108445214A (zh) * | 2018-02-02 | 2018-08-24 | 浙江艾明德生物科技有限公司 | 一种定量检测d-二聚体的试剂盒及制备方法 |
CN108780088A (zh) * | 2015-11-06 | 2018-11-09 | 维蒂卡实验室公司 | 在伴侣动物中检测炎症标志物和治疗炎性病症的方法 |
CN108993621A (zh) * | 2018-07-09 | 2018-12-14 | 浙江大学 | 一种用于数字酶联免疫检测的微小室阵列微流控芯片及方法 |
-
2018
- 2018-12-21 CN CN201811571829.1A patent/CN109725141B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103472235A (zh) * | 2013-08-26 | 2013-12-25 | 河北省科学院生物研究所 | 一种长效蛋白质溶液稳定剂 |
CN105445463A (zh) * | 2014-09-25 | 2016-03-30 | 苏州新波生物技术有限公司 | 一种戊肝IgG抗体检测试剂盒及其制备方法和应用 |
CN104730253A (zh) * | 2015-03-20 | 2015-06-24 | 国家纳米科学中心 | 一种基于点击化学的检测试纸条、检测方法和应用 |
CN108780088A (zh) * | 2015-11-06 | 2018-11-09 | 维蒂卡实验室公司 | 在伴侣动物中检测炎症标志物和治疗炎性病症的方法 |
CN107656043A (zh) * | 2017-09-21 | 2018-02-02 | 苏州新波生物技术有限公司 | 一种c反应蛋白磁微粒检测试剂盒及其使用方法 |
CN108008125A (zh) * | 2017-12-18 | 2018-05-08 | 江苏浩欧博生物医药股份有限公司 | 一种适用于免疫磁珠的冻干工作液和免疫磁珠冻干品及其制备方法 |
CN108226481A (zh) * | 2018-01-08 | 2018-06-29 | 宁波紫园医疗器械有限公司 | 一种用于化学发光免疫检测试剂的磁珠试剂 |
CN108445214A (zh) * | 2018-02-02 | 2018-08-24 | 浙江艾明德生物科技有限公司 | 一种定量检测d-二聚体的试剂盒及制备方法 |
CN108993621A (zh) * | 2018-07-09 | 2018-12-14 | 浙江大学 | 一种用于数字酶联免疫检测的微小室阵列微流控芯片及方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110426513A (zh) * | 2019-05-23 | 2019-11-08 | 武汉三鹰生物技术有限公司 | 一种无外源蛋白干扰的elisa标准品的制备方法 |
CN110632322A (zh) * | 2019-08-27 | 2019-12-31 | 迪瑞医疗科技股份有限公司 | 载脂蛋白c2校准品的冻干制备工艺 |
CN110632322B (zh) * | 2019-08-27 | 2021-07-13 | 迪瑞医疗科技股份有限公司 | 载脂蛋白c2校准品的冻干制备工艺 |
CN111999509A (zh) * | 2020-08-10 | 2020-11-27 | 深圳市宇诺生物技术有限公司 | 抗缪勒氏管激素测定试剂盒、制备方法及检测方法 |
CN112748242A (zh) * | 2020-12-21 | 2021-05-04 | 珠海碳云智能科技有限公司 | 用于多肽芯片技术平台检测的二抗缓冲封闭液、包括其的试剂盒及其应用 |
CN113005117A (zh) * | 2021-02-26 | 2021-06-22 | 北京中科生仪科技有限公司 | 一种磁珠干化保护液、干化磁珠及其制备方法 |
CN113005117B (zh) * | 2021-02-26 | 2021-11-09 | 北京中科生仪科技有限公司 | 一种磁珠干化保护液、干化磁珠及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109725141B (zh) | 2022-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109725141A (zh) | Sa-磁珠冻干工作液、sa-磁珠冻干品及冻干品的制备方法 | |
Costantino et al. | Lyophilization of biopharmaceuticals | |
CN1209067A (zh) | 活疫苗的稳定剂 | |
US20210223262A1 (en) | Lyosphere critical reagent kit | |
CN111226902B (zh) | 一种外泌体保存液及外泌体的保存方法 | |
AU2012312817B2 (en) | Customized quality controls for analytical assays | |
CN108226481A (zh) | 一种用于化学发光免疫检测试剂的磁珠试剂 | |
EP3411499B1 (en) | Dried amplification compositions | |
Lim et al. | Process cycle development of freeze drying for therapeutic proteins with stability evaluation | |
ES2674522T3 (es) | Composición liofilizada | |
CN110747263B (zh) | 一种冻干添加剂及荧光pcr反应混合物干粉和制备方法 | |
CN102892409B (zh) | 用于保存铝盐佐剂和铝盐-佐剂化疫苗的方法 | |
JP4865588B2 (ja) | 検査デバイスの標識体部の形成方法及びラテラルフロー免疫測定用検査デバイス | |
CN117159480B (zh) | 一种重组人IFN-γ蛋白冻干小球及其制备方法和应用 | |
CN107502567B (zh) | 发光杆菌冻干粉及其制备方法 | |
CN114752703A (zh) | 一种新型冠状病毒核酸的冻干型检测试剂及其制备方法 | |
CN116183903A (zh) | 一种用于AlphaLISA检测的冻干保护剂组合物及其制备方法 | |
Prado et al. | Lyophilization of molecular biology reactions: A review | |
Berge et al. | Preservation of enteroviruses by freeze-drying | |
CN105816879A (zh) | 用于提高冻干病毒疫苗在常温下保存的效力的冻干稳定剂 | |
CN112114140A (zh) | 一种新型冠状病毒IgA抗体胶体金检测试剂盒 | |
Phillips et al. | A study of water binding in lyophilized viral vaccine systems | |
CN111103432B (zh) | 一种促甲状腺激素受体的冻干辅助制剂及冻干方法 | |
CN104419644B (zh) | 一种发光细菌冻干制剂及其制备方法 | |
CN117442567A (zh) | 一种核心链霉亲和素冻干粉的制备方法和检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190729 Address after: 523871 Room 301, 3rd floor, 368 Zhenan Middle Road, Sha Community, Chang'an Town, Dongguan City, Guangdong Province Applicant after: Dongguan Dongyang Sunshine Medical Intelligent Device R&D Co.,Ltd. Address before: 523871 No. 368 Zhenan Middle Road, Chang'an Town, Dongguan City, Guangdong Province Applicant before: DONGGUAN HEC TECH R&D Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of SA magnetic bead freeze-drying working solution, SA magnetic bead freeze-drying product and freeze-drying product Effective date of registration: 20221114 Granted publication date: 20220429 Pledgee: China Development Bank Shenzhen Branch Pledgor: Dongguan Dongyang Sunshine Medical Intelligent Device R&D Co.,Ltd. Registration number: Y2022980021906 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231117 Granted publication date: 20220429 Pledgee: China Development Bank Shenzhen Branch Pledgor: Dongguan Dongyang Sunshine Medical Intelligent Device R&D Co.,Ltd. Registration number: Y2022980021906 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation methods for SA magnetic bead lyophilized working solution, SA magnetic bead lyophilized product, and lyophilized product Effective date of registration: 20231121 Granted publication date: 20220429 Pledgee: China Development Bank Shenzhen Branch Pledgor: Dongguan Dongyang Sunshine Medical Intelligent Device R&D Co.,Ltd. Registration number: Y2023980066753 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |